PTK2 and prostate carcinoma: Moreover, there was a reduction in attachment of TNBC and prostate cancer cells to vitronectin and fibronectin in ERK5 knockout cells via reduction in the FAK/proline-rich tyrosine kinase 2 (PYK2) interaction [78].